Reshaping the Clinical Trial Ecosystem Through a Regulatory Lens: The 2026 GCP Revision and Its Impact

XU Yan, ZHANG Hai-hong, ZHANG Ping, ZHANG Xiao-fang, LI Hai-yan

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (10) : 56-63.

PDF(3590 KB)
PDF(3590 KB)
China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (10) : 56-63. DOI: 10.3969/j.issn.1673-5390.2026.10.006
Research of Regulatory Science

Reshaping the Clinical Trial Ecosystem Through a Regulatory Lens: The 2026 GCP Revision and Its Impact

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 0(10): 56-63 https://doi.org/10.3969/j.issn.1673-5390.2026.10.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3590 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © China Food Drug Administration, All Rights Reserved.
Tel: 010-83025781　
Powered by Beijing Magtech Co. Ltd,.

/

〈 〉